Treatment of rat spinal cord injury with the neurotrophic factor Albumin-Oleic acid: Translational application for paralysis, spasticity and pain

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Avila Martin, Gerardo ^a   Galan Arriero, Iriana ^a   Gómez Soriano, Julio ^a,b   Taylor, Julian ^a  

^a HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALBUMIN OLEIC ACID COMPLEX; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NEUROTROPHIC FACTOR; OLEIC ACID; UNCLASSIFIED DRUG; ALBUMINOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; LOCOMOTION; MALE; MICROGLIA; MOTOR PERFORMANCE; NOCICEPTION; NONHUMAN; PAIN; PARALYSIS; PROTEIN PHOSPHORYLATION; RAT; REFLEX; SPASTICITY; SPINAL CORD INJURY; TIBIALIS ANTERIOR MUSCLE; ANIMAL; TREATMENT OUTCOME; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ALBUMINS; ANIMALS; MUSCLE SPASTICITY; OLEIC ACIDS; PAIN; PARALYSIS; RATS; RATS, WISTAR; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 80055064642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026107     Document Type: Article

References (93)

1. Sköld C, Levi R, Seiger A, (1999) Spasticity after traumatic spinal cord injury: nature, severity, and location. Arch Phys Med Rehabil 80: 1548-1557.
2. Dietz V, Sinkjaer T, (2007) Spastic movement disorder: impaired reflex function and altered muscle mechanics. Lancet Neurol 6: 725-733.
3. Finnerup NB, Jensen TS, (2004) Spinal cord injury pain-mechanisms and treatment. Eur J Neurol 11: 73-82.
4. Finnerup NB, Sorensen L, Biering-Sorensen F, Johannesen IL, Jensen TS, (2007) Segmental hypersensitivity and spinothalamic function in spinal cord injury pain. Exp Neurol 207: 139-149.
5. Wasner G, Lee BB, Engel S, McLachlan E, (2008) Residual spinothalamic tract pathways predict development of central pain after spinal cord injury. Brain 131: 2387-2400.
6. Dietz V, Grillner S, Trepp A, Hubli M, Bolliger M, (2009) Changes in spinal reflex and locomotor activity after a complete spinal cord injury: a common mechanism? Brain 132: 2196-2205.
7. Kwon BK, Okon EB, Plunet W, Baptiste D, Fouad K, et al. (2011) A Systematic Review of Directly Applied Biologic Therapies for Acute Spinal Cord Injury. J Neurotrauma 28: 1589-610.
8. Hagg T, Oudega M, (2006) Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma 23: 264-280.
9. Kakulas BA, (2004) Neuropathology: the foundation for new treatments in spinal cord injury. Spinal Cord 42: 549-563.
10. Dietz V, Curt A, (2006) Neurological aspects of spinal-cord repair: promises and challenges. Lancet Neurol 5: 688-694.
11. Bradbury EJ, McMahon SB, (2006) Spinal cord repair strategies: why do they work? Nat Rev Neurosci 7: 644-653.
12. Gomez-Soriano J, Goiriena E, Taylor J, (2010) Spasticity therapy reacts to astrocyte GluA1 receptor upregulation following spinal cord injury. Br J Pharmacol 161: 972-975.
13. Kwon BK, Okon EB, Tsai E, Beattie MS, Bresnahan JC, et al. (2011) A Grading System To Evaluate Objectively the Strength of Pre-Clinical Data of Acute Neuroprotective Therapies for Clinical Translation in Spinal Cord Injury. J Neurotrauma 28: 1525-43.
14. Grossman SD, Wolfe BB, Yasuda RP, Wrathall JR, (2000) Changes in NMDA receptor subunit expression in response to contusive spinal cord injury. J Neurochem 75: 174-184.
15. Hefferan MP, Kucharova K, Kinjo K, Kakinohana O, Sekerkova G, et al. (2007) Spinal astrocyte glutamate receptor 1 overexpression after ischemic insult facilitates behavioral signs of spasticity and rigidity. J Neurosci 27: 11179-11191.
16. Hains BC, Waxman SG, (2006) Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 26: 4308-4317.
17. Li X, Murray K, Harvey PJ, Ballou EW, Bennett DJ, (2007) Serotonin facilitates a persistent calcium current in motoneurons of rats with and without chronic spinal cord injury. J Neurophysiol 97: 1236-1246.
18. Hains BC, Everhart AW, Fullwood SD, Hulsebosch CE, (2002) Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat. Exp Neurol 175: 347-362.
19. Tabernero A, Velasco A, Granda B, Lavado EM, Medina JM, (2002) Transcytosis of albumin in astrocytes activates the sterol regulatory element-binding protein-1, which promotes the synthesis of the neurotrophic factor oleic acid. J Biol Chem 277: 4240-4246.
20. Rodriguez-Rodriguez RA, Tabernero A, Velasco A, Lavado EM, Medina JM, (2004) The neurotrophic effect of oleic acid includes dendritic differentiation and the expression of the neuronal basic helix-loop-helix transcription factor NeuroD2. J Neurochem 88: 1041-1051.
21. Cain LD, Nie L, Hughes MG, Johnson K, Echetebu C, et al. (2007) Serum albumin improves recovery from spinal cord injury. J Neurosci Res 85: 1558-1567.
22. King VR, Huang WL, Dyall SC, Curran OE, Priestley JV, et al. (2006) Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J Neurosci 26: 4672-4680.
23. Hamilton JA, Era S, Bhamidipati SP, Reed RG, (1991) Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Proc Natl Acad Sci U S A 88: 2051-2054.
24. Graven-Nielsen T, Aspegren KS, Henriksson KG, Bengtsson M, Sorensen J, et al. (2000) Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 85: 483-491.
25. Curatolo M, Petersen-Felix S, Arendt-Nielsen L, Zbinden AM, (1997) Spinal anaesthesia inhibits central temporal summation. Br J Anaesth 78: 88-89.
26. Bennett DJ, Sanelli L, Cooke CL, Harvey PJ, Gorassini MA, (2004) Spastic long-lasting reflexes in the awake rat after sacral spinal cord injury. J Neurophysiol 91: 2247-2258.
27. Hornby TG, Rymer WZ, Benz EN, Schmit BD, (2003) Windup of flexion reflexes in chronic human spinal cord injury: a marker for neuronal plateau potentials? J Neurophysiol 89: 416-426.
28. Jones CA, Yang JF, (1994) Reflex behavior during walking in incomplete spinal-cord-injured subjects. Exp Neurol 128: 239-248.
29. Clarke RW, Ford TW, Taylor JS, (1989) Reflex actions of selective stimulation of sural nerve C fibres in the rabbit. Q J Exp Physiol 74: 681-690.
30. Adam F, Gairard AC, Chauvin M, Le BD, Guirimand F, (2001) Effects of sufentanil and NMDA antagonists on a C-fibre reflex in the rat. Br J Pharmacol 133: 1013-1022.
31. Gozariu M, Bragard D, Willer JC, Le BD, (1997) Temporal summation of C-fiber afferent inputs: competition between facilitatory and inhibitory effects on C-fiber reflex in the rat. J Neurophysiol 78: 3165-3179.
32. Clarke RW, Eves S, Harris J, Peachey JE, Stuart E, (2002) Interactions between cutaneous afferent inputs to a withdrawal reflex in the decerebrated rabbit and their control by descending and segmental systems. Neuroscience 112: 555-571.
33. Falinower S, Willer JC, Junien JL, Le Bars D, (1994) A C-fiber reflex modulated by heterotopic noxious somatic stimuli in the rat. J Neurophysiol 72: 194-213.
34. Taylor JS, Neal RI, Harris J, Ford TW, Clarke RW, (1991) Prolonged inhibition of a spinal reflex after intense stimulation of distant peripheral nerves in the decerebrated rabbit. J Physiol 437: 71-83.
35. Taylor JS, Friedman RF, Munson JB, Vierck CJ Jr, (1997) Stretch hyperreflexia of triceps surae muscles in the conscious cat after dorsolateral spinal lesions. J Neurosci 17: 5004-5015.
36. Taylor J, Munson J, Vierck CJ Jr, (1999) Effects of dorsolateral spinal lesions on stretch reflex threshold and stiffness in awake cats. Eur J Neurosci 11: 363-368.
37. Mullner A, Gonzenbach RR, Weinmann O, Schnell L, Liebscher T, et al. (2008) Lamina-specific restoration of serotonergic projections after Nogo-A antibody treatment of spinal cord injury in rats. Eur J Neurosci 27: 326-333.
38. Deumens R, Koopmans GC, Joosten EA, (2005) Regeneration of descending axon tracts after spinal cord injury. Prog Neurobiol 77: 57-89.
39. Raineteau O, Schwab ME, (2001) Plasticity of motor systems after incomplete spinal cord injury. Nat Rev Neurosci 2: 263-273.
40. Roby-Brami A, Bussel B, Willer JC, Le Bars D, (1987) An electrophysiological investigation into the pain-relieving effects of heterotopic nociceptive stimuli. Probable involvement of a supraspinal loop. Brain 110 (Pt 6): 1497-1508.
41. Taylor J, Avila-Martin G, Mazarío Torrijos J, (2009) Complexes of albumin with omega-9 monounsaturated acids for the treatment of medullary lesions. PCT/ES2009/ 070252.
42. Jasmin L, Ohara PT, (2001) Long-term intrathecal catheterization in the rat. J Neurosci Methods 110: 81-89.
43. Elliot KAC, (1969) The use of slices. In: Lajtha A, editors. Handbook of Neurochemistry, Vol 2. New York Plenum Press pp. 103-114.
44. Young W, (2002) Spinal cord contusion models. Prog Brain Res 137: 231-255.
45. Basso DM, Beattie MS, Bresnahan JC, Anderson DK, Faden AI, et al. (1996) MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J Neurotrauma 13: 343-359.
46. Arevalo-Martin A, Vela JM, Molina-Holgado E, Borrell J, Guaza C, (2003) Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J Neurosci 23: 2511-2516.
47. Liu XG, Morton CR, Azkue JJ, Zimmermann M, Sandkuhler J, (1998) Long-term depression of C-fibre-evoked spinal field potentials by stimulation of primary afferent A delta-fibres in the adult rat. Eur J Neurosci 10: 3069-3075.
48. Gundersen HJ, Jensen EB, (1987) The efficiency of systematic sampling in stereology and its prediction. J Microsc 147: 229-263.
49. Huang WL, King VR, Curran OE, Dyall SC, Ward RE, et al. (2007) A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 130: 3004-3019.
50. Vahedi K, Atlan P, Joly F, Le BA, Evard D, et al. (2005) A 3-month double-blind randomised study comparing an olive oil- with a soyabean oil-based intravenous lipid emulsion in home parenteral nutrition patients. Br J Nutr 94: 909-916.
51. Bhattacharya AA, Grune T, Curry S, (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol 303: 721-732.
52. Vahidy WH, Ong WY, Farooqui AA, Yeo JF, (2006) Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain. Exp Brain Res 174: 781-785.
53. Kremer JM, Lawrence DA, Jubiz W, DiGiacomo R, Rynes R, et al. (1990) Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 33: 810-820.
54. Oh YT, Lee JY, Lee J, Kim H, Yoon KS, et al. (2009) Oleic acid reduces lipopolysaccharide-induced expression of iNOS and COX-2 in BV2 murine microglial cells: possible involvement of reactive oxygen species, p38 MAPK, and IKK/NF-kappaB signaling pathways. Neurosci Lett 464: 93-97.
55. Schmitt AB, Breuer S, Liman J, Buss A, Schlangen C, et al. (2003) Identification of regeneration-associated genes after central and peripheral nerve injury in the adult rat. BMC Neurosci 4: 8.
56. DeWille JW, Farmer SJ, (1992) Postnatal dietary fat influences mRNAS involved in myelination. Dev Neurosci 14: 61-68.
57. Granda B, Tabernero A, Tello V, Medina JM, (2003) Oleic acid induces GAP-43 expression through a protein kinase C-mediated mechanism that is independent of NGF but synergistic with NT-3 and NT-4/5. Brain Res 988: 1-8.
58. Giehl KM, Tetzlaff W, (1996) BDNF and NT-3, but not NGF, prevent axotomy-induced death of rat corticospinal neurons in vivo. Eur J Neurosci 8: 1167-1175.
59. Menei P, Montero-Menei C, Whittemore SR, Bunge RP, Bunge MB, (1998) Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord. Eur J Neurosci 10: 607-621.
60. Cadden SW, Villanueva L, Chitour D, LeBars D, (1983) Depression of activities of dorsal horn convergent neurones by propriospinal mechanisms triggered by noxious inputs; comparison with diffuse noxious inhibitory controls (DNIC). Brain Res 275: 1-11.
61. Courtine G, Song B, Roy RR, Zhong H, Herrmann JE, et al. (2008) Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury. Nat Med 14: 69-74.
62. Ward RE, Huang W, Curran OE, Priestley JV, Michael-Titus AT, (2010) Docosahexaenoic acid prevents white matter damage after spinal cord injury. J Neurotrauma 27: 1769-1780.
63. Alberts GL, Chio CL, Im WB, (2001) Allosteric modulation of the human 5-HT(7A) receptor by lipidic amphipathic compounds. Mol Pharmacol 60: 1349-1355.
64. Doly S, Fischer J, Brisorgueil MJ, Verge D, Conrath M, (2005) Pre- and postsynaptic localization of the 5-HT7 receptor in rat dorsal spinal cord: immunocytochemical evidence. J Comp Neurol 490: 256-269.
65. Hamon M, Kayser V, Bourgoin S, (2008) Neuropathic pain: Physiopathological mechanisms and therapeutic perspectives. Bull Acad Natl Med 192: 921-926.
66. Dogrul A, Ossipov MH, Porreca F, (2009) Differential mediation of descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 receptors. Brain Res 1280: 52-59.
67. Nagy GG, Watanabe M, Fukaya M, Todd AJ, (2004) Synaptic distribution of the NR1, NR2A and NR2B subunits of the N-methyl-d-aspartate receptor in the rat lumbar spinal cord revealed with an antigen-unmasking technique. Eur J Neurosci 20: 3301-3312.
68. Temkin R, Lowe D, Jensen P, Hatt H, Smith DO, (1997) Expression of glutamate receptor subunits in alpha-motoneurons. Brain Res Mol Brain Res 52: 38-45.
69. Prybylowski KL, Grossman SD, Wrathall JR, Wolfe BB, (2001) Expression of splice variants of the NR1 subunit of the N-methyl-D-aspartate receptor in the normal and injured rat spinal cord. J Neurochem 76: 797-805.
70. Xu XJ, Dalsgaard CJ, Wiesenfeld-Hallin Z, (1992) Spinal substance P and N-methyl-D-aspartate receptors are coactivated in the induction of central sensitization of the nociceptive flexor reflex. Neuroscience 51: 641-648.
71. Brenner GJ, Ji RR, Shaffer S, Woolf CJ, (2004) Peripheral noxious stimulation induces phosphorylation of the NMDA receptor NR1 subunit at the PKC-dependent site, serine-896, in spinal cord dorsal horn neurons. Eur J Neurosci 20: 375-384.
72. Roh DH, Seo HS, Yoon SY, Song S, Han HJ, et al. (2010) Activation of spinal alpha-2 adrenoceptors, but not mu-opioid receptors, reduces the intrathecal N-methyl-D-aspartate-induced increase in spinal NR1 subunit phosphorylation and nociceptive behaviors in the rat. Anesth Analg 110: 622-629.
73. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, et al. (2006) The cellular inflammatory response in human spinal cords after injury. Brain 129: 3249-3269.
74. Jones TB, McDaniel EE, Popovich PG, (2005) Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr Pharm Des 11: 1223-1236.
75. Holmoy T, Skorstad G, Roste LS, Scheie D, Alvik K, (2009) Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord. Clin Neurol Neurosurg 111: 708-712.
76. Feng X, Zhang F, Dong R, Li W, Liu J, et al. (2009) Intrathecal administration of clonidine attenuates spinal neuroimmune activation in a rat model of neuropathic pain with existing hyperalgesia. Eur J Pharmacol 614: 38-43.
77. Yezierski RP, (2009) Spinal cord injury pain: spinal and supraspinal mechanisms. J Rehabil Res Dev 46: 95-107.
78. Widerstrom-Noga EG, Finnerup NB, Siddall PJ, (2009) Biopsychosocial perspective on a mechanisms-based approach to assessment and treatment of pain following spinal cord injury. J Rehabil Res Dev 46: 1-12.
79. Biering-Sorensen F, Nielsen JB, Klinge K, (2006) Spasticity-assessment: a review. Spinal Cord 44: 708-722.
80. Nielsen JB, Crone C, Hultborn H, (2007) The spinal pathophysiology of spasticity-from a basic science point of view. Acta Physiol (Oxf) 189: 171-180.
81. Cruz-Almeida Y, Felix ER, Martinez-Arizala A, Widerstrom-Noga EG, (2009) Pain symptom profiles in persons with spinal cord injury. Pain Med 10: 1246-1259.
82. Gomez-Soriano J, Castellote JM, Perez-Rizo E, Esclarin A, Taylor JS, (2010) Voluntary ankle flexor activity and adaptive coactivation gain is decreased by spasticity during subacute spinal cord injury. Exp Neurol 224: 507-516.
83. Adams MM, Hicks AL, (2005) Spasticity after spinal cord injury. Spinal Cord 43: 577-586.
84. Taricco M, Pagliacci MC, Telaro E, Adone R, (2006) Pharmacological interventions for spasticity following spinal cord injury: results of a Cochrane systematic review. Eura Medicophys 42: 5-15.
85. Baastrup C, Finnerup NB, (2008) Pharmacological management of neuropathic pain following spinal cord injury CNS Drugs. 22: 455-475.
86. Tullis JL, (1977) Albumin. 2. Guidelines for clinical use. JAMA 237: 460-463.
87. Wang YF, Gwathmey JK, Zhang G, Soriano SG, He S, et al. (2005) Cerebrospinal fluid may mediate CNS ischemic injury. Cerebrospinal Fluid Res 2: 7.
88. Kratz F, (2008) Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132: 171-183.
89. Bhattacharya AA, Grune T, Curry S, (2000) Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol 303: 721-732.
90. Chuang VT, Kragh-Hansen U, Otagiri M, (2002) Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res 19: 569-577.
91. Banks WA, Broadwell RD, (1994) Blood to brain and brain to blood passage of native horseradish peroxidase, wheat germ agglutinin, and albumin: pharmacokinetic and morphological assessments. J Neurochem 62: 2404-2419.
92. Belayev L, Marcheselli VL, Khoutorova L, Rodriguez de Turco EB, Busto R, et al. (2005) Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection. Stroke 36: 118-123.
93. Bento-Abreu A, Tabernero A, Medina JM, (2007) Peroxisome proliferator-activated receptor-alpha is required for the neurotrophic effect of oleic acid in neurons. J Neurochem 103: 871-881.